Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

DRUG APPROVAL OVERHAUL PLANS

Nov. 11, 1991

APPOINTMENTS AND ADVANCEMENTS

Nov. 11, 1991

CENTOCOR LOSES $34.9 MILLION IN QUARTER

Nov. 11, 1991

RHODE ISLAND FINANCES MANUFACTURING PLANT

Nov. 8, 1991

PATENT FLASH

Nov. 8, 1991

NEORX DOUBLES COMMON STOCK

Nov. 8, 1991

MYCOGEN COMPLETES OFFERING

Nov. 8, 1991

SEPSIS MORTALITY DROPS IN ANTRIL TRIALS

Nov. 8, 1991

BTGC FINDS UNIQUE HIV TARGET

Nov. 8, 1991

ATHENA INCREASES SHARES IN OFFERING

Nov. 8, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...